Vertex Pharmaceuticals’ (VRTX) Outperform Rating Reiterated at William Blair
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at William Blair in a research note issued to investors on Friday,RTT News ...
Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...
Vertex Pharmaceuticals’ (VRTX) “Hold” Rating Reiterated at Needham & Company LLC
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “hold” rating reaffirmed by Needham & Company LLC in a report released on Friday,Benzinga reports. A number of other research ...
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...
Global Markets Report - 3 February
Pleas note: we will be discontinuing the Global Markets Report after 28 February. Australian shares are set to open lower, ...
Sunday 5:30p Weather
President Donald Trump signed an executive order authorizing the tariffs Saturday, which will go into effect Tuesday, ...
The Black Restaurant Challenge aims to uplift small businesses in Boston
Chesley "Sully" Sullenberger, known for the heroic landing of US Airways Flight 1549 on the Hudson River, weighed in on the ...
What are the implications of DeepSeek's emergence? Bernstein weighs in
Investing.com - Last weekend, a new name in the artificial intelligence arms race was becoming increasingly ubiquitous: ...
Two broad equities-relevant policy areas to watch around German elections
Following their investor field trip to Berlin ahead of Germany’s election next month, Morgan Stanley (NYSE:MS) strategists ...